Travere Therapeutics names new R&D head ahead of 2027 retirement

Go back to Travere Therapeutics names new R&D head ahead of 2027 retirement
(NASDAQ: TVTX) Delayed: 56.68 +0.42 (0.75%)
Previous Close $56.26    52 Week High
Open $54.80    52 Week Low
Day High $60.00    P/E N/A 
Day Low $54.32    EPS
Volume 1,369,313